Wissenschaftliche Publikationen Suche Suche Autor/in Forschungsgruppe Veröffentlichungsdatum Wirkungsfaktor Suchen Sortieren nach RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Reihenfolge AufsteigendAbsteigend Alp, Keziban Merve (1) Birchmeier, Walter Prof. Dr. (7) Blankenstein, Thomas Prof. Dr. (2) Blüthgen, Nils (1) Dahlmann, Mathias Dr. (29) Daniel, Peter Prof. Dr. (3) Fritsche, Raphaela Dr. (2) Hartl, Kimberly (1) Hübner, Norbert Prof. Dr. (1) Ivics, Zoltan Dr. (2) Izsvak, Zsuzsanna Dr. (2) Janke, Jürgen Dr. (1) Janz, Martin Dr. (1) Keller, Ulrich Dr. med. (1) Kobelt, Dennis Dr. (51) Koch, Gudrun (1) Leutz, Achim Prof. Dr. (2) Malchin, Victoria (1) Mertins, Philipp Dr. (4) Na, Il-Kang Dr. (1) Nazare, Marc (1) Nguyen, Tam Hoai Dr. (1) Nimptsch, Katharina Dr. (1) Pezzutto, Antonio Prof. Dr. (3) Pischon, Tobias Prof. Dr. (1) Popp, Oliver Dr. (3) Rathjen, Fritz Prof. Dr. (1) Rehm, Armin Dr. (1) Röefzaad, Claudia (1) Schlag, Peter M. Prof. Dr. (378) Schmitt, Clemens Prof. Dr. (2) Schöpe, Paul Curtis (2) Schroeder, Leif Dr. (1) Simon, Mareike Dr. (1) Specker, Edgar Dr. (2) Sporbert, Anje Dr. (1) Stein, Ulrike Prof. Dr. (187) Torke, Sebastian Dr. (3) Uckert, Wolfgang Prof. Dr. (1) Veltsista, Paraskevi Danai (1) von Kries, Jens Peter Dr. (2) Walther, Wolfgang Prof. Dr. (144) Wenzel, Katrin Dr. (1) Willimsky, Gerald Dr. (1) Willnow, Thomas Prof. Dr. (1) Wolf, Jana Prof. Dr. (1) Zimmermann, Karin Dr. (1) (-) Herse, Florian PD Dr. (1) (-) Smith, Janice (16) (-) Sperling, Silke Prof. Dr. (1) AG Müller/Dechend (ECRC) (87) Animal Phenotyping (7) Clinical Research Unit (1) Entwicklungsneurobiologie (1) Genetik und Genomik von Herz- Kreislauferkrankungen (5) Genetik von Angeborenen Herzerkrankungen (3) Genomics (1) Hypertonie-vermittelter Endorganschaden (87) Hypertonie bedingte Endorganschäden (87) Kardiale MRT (1) Mobile DNA (2) Molekularbiologie von Hormonen im Herz-Kreislaufssystem (8) Proteomics (1) Proteomics and Metabolomics (1) Translational Bioinformatics (1) (-) Translationale Onkologie solider Tumore (18) 2006 (1) 2007 (1) 2008 (1) 2009 (2) 2010 (1) 2011 (1) 2012 (1) 2013 (1) 2014 (1) 2016 (1) 2017 (2) 2020 (1) 2021 (1) 2022 (1) 2023 (2) 18 Ergebnisse: Active Filter: Herse, Florian PD Dr.Smith, JaniceSperling, Silke Prof. Dr.Translationale Onkologie solider Tumore Sortieren: Treffgenauigkeit Neueste nach älteste Älteste nach neueste 30. Mai 2014 / Oncotarget RAGE mediates S100A4-induced cell motility via MAPK/ERK and hypoxia signaling and is a prognostic biomarker for human colorectal cancer metastasis M. Dahlmann A. Okhrimenko P. Marcinkowski M. Osterland P. Herrmann J. Smith C.W. Heizmann P.M. Schlag U. Stein 01. November 2006 / Gastroenterology The metastasis-associated gene S100A4 is a novel target of beta-catenin/T-cell factor (TCF) signaling in colon cancer U. Stein F. Arlt W. Walther J. Smith T. Waldman E.D. Harris S.D. Mertins C.W. Heizmann D. Allard W. Birchmeier P.M. Schlag R.H. Shoemaker 01. Mai 2007 / Biol Chem Expression of the protein phosphatase 1 inhibitor KEPI is downregulated in breast cancer cell lines and tissues and involved in the regulation of the tumor suppressor EGR1 via the MEK-ERK pathway K. Wenzel K. Daskalow F. Herse S. Seitz U. Zacharias J.A. Schenk H. Schulz N. Huebner B. Micheel P.M. Schlag K.J. Osterziel C. Ozcelik S. Scherneck B. Jandrig 01. Januar 2009 / Nat Med MACC1, a newly identified key regulator of HGF-MET signaling, predicts colon cancer metastasis U. Stein W. Walther F. Arlt H. Schwabe J. Smith I. Fichtner W. Birchmeier P.M. Schlag 02. Dezember 2010 / PLoS Genet Identification of Y-box binding protein 1 as a core regulator of MEK/ERK pathway-dependent gene signatures in colorectal cancer cells K. Juerchott R.J. Kuban T. Krech N. Blüthgen U. Stein W. Walther C. Friese S.M. Kielbasa U. Ungethuem P. Lund T. Knoesel W. Kemmner M. Morkel J. Fritzmann P.M. Schlag W. Birchmeier T. Krueger S. Sperling C. Sers H.D. Royer H. Herzel R. Schaefer 01. Februar 2011 / Neoplasia Intervening in beta-catenin signaling by sulindac inhibits S100A4-dependent colon cancer metastasis U. Stein F. Arlt J. Smith U. Sack P. Herrmann W. Walther M. Lemm I. Fichtner R.H. Shoemaker P.M. Schlag 01. August 2012 / Clin Exp Metastasis In vivo imaging of colorectal cancer growth and metastasis by targeting MACC1 with shRNA in xenografted mice A. Pichorner U. Sack D. Kobelt I. Kelch F. Arlt J. Smith W. Walther P.M. Schlag U. Stein 01. Dezember 2013 / Neuro Oncol Impact of MACC1 on human malignant glioma progression and patients' unfavorable prognosis C. Hagemann S. Fuchs C.M. Monoranu P. Herrmann J. Smith T. Hohmann U. Grabiec A.F. Kessler F. Dehghani M. Loehr R.I. Ernestus G.H. Vince U. Stein 01. August 2009 / Cell Cycle MACC1 controls Met: What a difference an Sp1 site makes U. Stein J. Smith W. Walther F. Arlt 01. August 2017 / Ann Oncol Prognostic value of MACC1 and proficient mismatch repair status for recurrence risk prediction in stage II colon cancer patients: the BIOGRID studies U.P. Rohr P. Herrmann K. Ilm H. Zhang S. Lohmann A. Reiser A. Muranyi J. Smith S. Burock M. Osterland K. Leith S. Singh P. Brunhoeber R. Bowermaster J. Tie M. Christie H.L. Wong P. Waring K. Shanmugam P. Gibbs U. Stein Seitennummerierung Aktuelle Seite 1 Seite 2 Nächste Seite Next › Letzte Seite Last »
30. Mai 2014 / Oncotarget RAGE mediates S100A4-induced cell motility via MAPK/ERK and hypoxia signaling and is a prognostic biomarker for human colorectal cancer metastasis M. Dahlmann A. Okhrimenko P. Marcinkowski M. Osterland P. Herrmann J. Smith C.W. Heizmann P.M. Schlag U. Stein
01. November 2006 / Gastroenterology The metastasis-associated gene S100A4 is a novel target of beta-catenin/T-cell factor (TCF) signaling in colon cancer U. Stein F. Arlt W. Walther J. Smith T. Waldman E.D. Harris S.D. Mertins C.W. Heizmann D. Allard W. Birchmeier P.M. Schlag R.H. Shoemaker
01. Mai 2007 / Biol Chem Expression of the protein phosphatase 1 inhibitor KEPI is downregulated in breast cancer cell lines and tissues and involved in the regulation of the tumor suppressor EGR1 via the MEK-ERK pathway K. Wenzel K. Daskalow F. Herse S. Seitz U. Zacharias J.A. Schenk H. Schulz N. Huebner B. Micheel P.M. Schlag K.J. Osterziel C. Ozcelik S. Scherneck B. Jandrig
01. Januar 2009 / Nat Med MACC1, a newly identified key regulator of HGF-MET signaling, predicts colon cancer metastasis U. Stein W. Walther F. Arlt H. Schwabe J. Smith I. Fichtner W. Birchmeier P.M. Schlag
02. Dezember 2010 / PLoS Genet Identification of Y-box binding protein 1 as a core regulator of MEK/ERK pathway-dependent gene signatures in colorectal cancer cells K. Juerchott R.J. Kuban T. Krech N. Blüthgen U. Stein W. Walther C. Friese S.M. Kielbasa U. Ungethuem P. Lund T. Knoesel W. Kemmner M. Morkel J. Fritzmann P.M. Schlag W. Birchmeier T. Krueger S. Sperling C. Sers H.D. Royer H. Herzel R. Schaefer
01. Februar 2011 / Neoplasia Intervening in beta-catenin signaling by sulindac inhibits S100A4-dependent colon cancer metastasis U. Stein F. Arlt J. Smith U. Sack P. Herrmann W. Walther M. Lemm I. Fichtner R.H. Shoemaker P.M. Schlag
01. August 2012 / Clin Exp Metastasis In vivo imaging of colorectal cancer growth and metastasis by targeting MACC1 with shRNA in xenografted mice A. Pichorner U. Sack D. Kobelt I. Kelch F. Arlt J. Smith W. Walther P.M. Schlag U. Stein
01. Dezember 2013 / Neuro Oncol Impact of MACC1 on human malignant glioma progression and patients' unfavorable prognosis C. Hagemann S. Fuchs C.M. Monoranu P. Herrmann J. Smith T. Hohmann U. Grabiec A.F. Kessler F. Dehghani M. Loehr R.I. Ernestus G.H. Vince U. Stein
01. August 2009 / Cell Cycle MACC1 controls Met: What a difference an Sp1 site makes U. Stein J. Smith W. Walther F. Arlt
01. August 2017 / Ann Oncol Prognostic value of MACC1 and proficient mismatch repair status for recurrence risk prediction in stage II colon cancer patients: the BIOGRID studies U.P. Rohr P. Herrmann K. Ilm H. Zhang S. Lohmann A. Reiser A. Muranyi J. Smith S. Burock M. Osterland K. Leith S. Singh P. Brunhoeber R. Bowermaster J. Tie M. Christie H.L. Wong P. Waring K. Shanmugam P. Gibbs U. Stein